Delivery Order SPE2DB20D1110-SPE2DB24FK10L

Award Date 4/9/24
Potential Completion Date 4/10/24
Potential Value $4.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. The contract has a ceiling value of $1,521.95 and a period of performance through April 1, 2024. This award is associated with a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA, which serves as the primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. The contract has a ceiling value of $6,557.58 and a period of performance through April 4, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, which has a potential value of up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. The contract has a ceiling value of $16,047.84 and an ultimate completion date of March 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,564,235,496 units of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. The contract has a ceiling value of $5,480.75 and a period of performance through April 11, 2024. This delivery order is likely issued under AmerisourceBergen Drug Corp's existing indefinite delivery contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. The $3,887.63 contract has an ultimate completion date of April 1, 2024. This delivery order is a part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. The contract has a potential value of $8,675.27 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used for this award. This delivery order is issued under Amerisourcebergen's...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide COSENTYX SNRDY 300MG DOSE-2PENML. The contract has a ceiling value of $4,565.85 and a performance period through March 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $12,486.91 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, with a period of performance ending on March 13, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded by DLA to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. The contract has a potential value of $2,158.21 and a completion date of February 21, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp with a potential value of up...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. The contract has a ceiling value of $3,417.60 and a period of performance through April 2, 2024. This award is associated with a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a...
  • SPE2DB20D1110
    Indefinite Delivery Contract
  • SPE2DB20D1110-SPE2DB24FK10L
    Delivery Order

The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract (SPE2DB24FK10L) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. The contract has a ceiling value of $4,118.44 and a period of performance through April 10, 2024. This delivery order contract is issued under AmerisourceBergen Drug Corp's existing indefinite delivery contract (SPE2DB20D1110) with DLA, which has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. This overarching indefinite delivery contract serves as the primary vehicle for AmerisourceBergen Drug Corp to supply a range of pharmaceuticals and medical supplies to DLA Troop Support Medical in support of the Department of Defense. No set-aside designations have been used for these contract awards.

Generated 7/9/24, 2:14 PM